Literature DB >> 12000744

Intracellular processing of metalloprotease disintegrin ADAM12.

Yi Cao1, Qing Kang, Zhefeng Zhao, Anna Zolkiewska.   

Abstract

ADAM12 has been implicated in cell-cell interactions in myogenesis and cancer, but the structure of the mature form of ADAM12 is not known, and its localization on the cell surface has been questioned. In this report, we show that full-length ADAM12 is N-glycosylated in the endoplasmic reticulum (ER) and proteolytically processed in the trans-Golgi network to an approximately 90-kDa form. The approximately 90-kDa form, which lacks the prodomain, was the predominant form present at the cell surface. Replacement of Leu(73) in the putative alpha-helical region in the prodomain with proline resulted in retention of ADAM12 in the ER and a complete lack of its processing. However, deletion of the entire pro- and metalloprotease domains did not affect the processing and trafficking of ADAM12. In contrast, replacement of the cytoplasmic domain of ADAM12 with that of ADAM9 or adding a c-Myc tag at the C terminus led to a significant increase in transport of the protein to the cell surface. These results suggest that the cytoplasmic domain of ADAM12 plays an important role in regulating ADAM12 exit from the ER. We conclude that properly folded mouse ADAM12, after passing a rate-limiting step of exit from the ER, is processed in the secretory pathway and reaches the cell surface, where it can mediate adhesion-mediated signaling.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12000744     DOI: 10.1074/jbc.M110814200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  The role of SnoN in transforming growth factor beta1-induced expression of metalloprotease-disintegrin ADAM12.

Authors:  Emilia Solomon; Hui Li; Sara Duhachek Muggy; Emilia Syta; Anna Zolkiewska
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

2.  Metalloprotease-disintegrin ADAM12 expression is regulated by Notch signaling via microRNA-29.

Authors:  Hui Li; Emilia Solomon; Sara Duhachek Muggy; Danqiong Sun; Anna Zolkiewska
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

3.  Selective modulation of integrin-mediated cell migration by distinct ADAM family members.

Authors:  Jing Huang; Lance C Bridges; Judith M White
Journal:  Mol Biol Cell       Date:  2005-08-03       Impact factor: 4.138

4.  Role of metalloprotease disintegrin ADAM12 in determination of quiescent reserve cells during myogenic differentiation in vitro.

Authors:  Yi Cao; Zhefeng Zhao; Joanna Gruszczynska-Biegala; Anna Zolkiewska
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

5.  Structural characterization of the ectodomain of a disintegrin and metalloproteinase-22 (ADAM22), a neural adhesion receptor instead of metalloproteinase: insights on ADAM function.

Authors:  Heli Liu; Ann H R Shim; Xiaolin He
Journal:  J Biol Chem       Date:  2009-08-18       Impact factor: 5.157

6.  ADAM10 missense mutations potentiate β-amyloid accumulation by impairing prodomain chaperone function.

Authors:  Jaehong Suh; Se Hoon Choi; Donna M Romano; Moira A Gannon; Andrea N Lesinski; Doo Yeon Kim; Rudolph E Tanzi
Journal:  Neuron       Date:  2013-09-19       Impact factor: 17.173

7.  ADAM12 is selectively overexpressed in human glioblastomas and is associated with glioblastoma cell proliferation and shedding of heparin-binding epidermal growth factor.

Authors:  Takahide Kodama; Eiji Ikeda; Aiko Okada; Takashi Ohtsuka; Masayuki Shimoda; Takayuki Shiomi; Kazunari Yoshida; Mitsutoshi Nakada; Eiko Ohuchi; Yasunori Okada
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

8.  ADAM12 and alpha9beta1 integrin are instrumental in human myogenic cell differentiation.

Authors:  Peggy Lafuste; Corinne Sonnet; Bénédicte Chazaud; Patrick A Dreyfus; Romain K Gherardi; Ulla M Wewer; François-Jérôme Authier
Journal:  Mol Biol Cell       Date:  2004-12-01       Impact factor: 4.138

9.  RACK1, a new ADAM12 interacting protein. Contribution to liver fibrogenesis.

Authors:  Katia Bourd-Boittin; Hélène Le Pabic; Dominique Bonnier; Annie L'Helgoualc'h; Nathalie Théret
Journal:  J Biol Chem       Date:  2008-07-11       Impact factor: 5.157

10.  An essential role of metalloprotease-disintegrin ADAM12 in triple-negative breast cancer.

Authors:  Hui Li; Sara Duhachek-Muggy; Yue Qi; Yan Hong; Fariba Behbod; Anna Zolkiewska
Journal:  Breast Cancer Res Treat       Date:  2012-08-29       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.